Antidepressive therapy
July 27, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2799241 2909462 3845770 3916899 Osmotically driven active agent dispenser Apparatus for tracking moving workpiece by a laser beam Process for forming outlet passageways in pills using a laser Osmotic system with distribution zone for dispensing beneficial agent Process for manufacturing device with dispersion zone Osmotic device with hydrogel driving member InventorsApplicationNo. 507890 filed on 07/27/1995US Classes:424/422, Implant or insert424/457, Sustained or differential release424/468, Sustained or differential release type424/473, With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.)514/252.19, Five-membered nitrogen hetero ring attached directly or indirectly to the 1,3-diazine ring by nonionic bonding514/253.09, Five-membered nitrogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding514/254.08Polycyclo ring system having the additional five-membered nitrogen hetero ring as one of the cyclosExaminersPrimary: Reamer, James H.Attorney, Agent or FirmInternational ClassA61K 009/24AbstractA dosage form is provided for administering a drug of the formula ##STR1## to a patient to produce an anxiolytic benefit in the patient. | |
